BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28115938)

  • 1. Severe Rhabdomyolysis as Complication of Interaction between Atorvastatin and Fusidic Acid in a Patient in Lifelong Antibiotic Prophylaxis: A Dangerous Combination.
    Nandy A; Gaïni S
    Case Rep Med; 2016; 2016():4705492. PubMed ID: 28115938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin.
    Magee CN; Medani SA; Leavey SF; Conlon PJ; Clarkson MR
    Am J Kidney Dis; 2010 Nov; 56(5):e11-5. PubMed ID: 20888103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis with atorvastatin and fusidic acid.
    O'Mahony C; Campbell VL; Al-Khayatt MS; Brull DJ
    Postgrad Med J; 2008 Jun; 84(992):325-7. PubMed ID: 18644925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhabdomyolysis Induced by Coadministration of Fusidic Acid and Atorvastatin: A Case Report and Comprehensive Review of the Literature.
    Patoulias D; Michailidis T; Papatolios T; Papadopoulos R; Keryttopoulos P
    Case Rep Nephrol; 2017; 2017():2187264. PubMed ID: 29119029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions.
    Deljehier T; Pariente A; Miremont-Salamé G; Haramburu F; Nguyen L; Rubin S; Rigothier C; Théophile H
    Br J Clin Pharmacol; 2018 May; 84(5):1057-1063. PubMed ID: 29337401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin.
    Teckchandani S; Robertson S; Almond A; Donaldson K; Isles C
    J R Coll Physicians Edinb; 2010 Mar; 40(1):33-6. PubMed ID: 21125037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
    Gabignon C; Zeller V; Le Guyader N; Desplaces N; Lidove O; Ziza JM
    Rev Med Interne; 2013 Jan; 34(1):39-41. PubMed ID: 23102978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhabdomyolysis with concurrent atorvastatin and diltiazem.
    Lewin JJ; Nappi JM; Taylor MH
    Ann Pharmacother; 2002 Oct; 36(10):1546-9. PubMed ID: 12243603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle Damage Due to Fusidic Acid-Statin Interaction: Review of 75 Cases From the French Pharmacovigilance Database and Literature Reports.
    Bataillard M; Beyens MN; Mounier G; Vergnon-Miszczycha D; Bagheri H; Cathebras P
    Am J Ther; 2019; 26(3):e375-e379. PubMed ID: 29189310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed presentation of severe rhabdomyolysis leading to acute kidney injury following atorvastatin-gemfibrozil combination therapy: a case report.
    Dalugama C; Pathirage M; Kularatne SAM
    J Med Case Rep; 2018 May; 12(1):143. PubMed ID: 29784023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine.
    Maltz HC; Balog DL; Cheigh JS
    Ann Pharmacother; 1999 Nov; 33(11):1176-9. PubMed ID: 10573315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
    Wenisch C; Krause R; Fladerer P; El Menjawi I; Pohanka E
    Am J Med; 2000 Jul; 109(1):78. PubMed ID: 10991749
    [No Abstract]   [Full Text] [Related]  

  • 13. Levofloxacin-induced rhabdomyolysis in a patient on concurrent atorvastatin: Case report and literature review.
    Bouchard J; De La Pena N; Oleksiuk LM
    J Clin Pharm Ther; 2019 Dec; 44(6):966-969. PubMed ID: 31407828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presumed interaction of fusidic acid with simvastatin.
    Burtenshaw AJ; Sellors G; Downing R
    Anaesthesia; 2008 Jun; 63(6):656-8. PubMed ID: 18477279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin.
    Mackay JW; Fenech ME; Myint KS
    Br J Hosp Med (Lond); 2012 Feb; 73(2):106-7. PubMed ID: 22504754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe statin-induced rhabdomyolysis mimicking Guillain-Barré syndrome in four patients with diabetes mellitus treated with fusidic acid.
    Collidge TA; Razvi S; Nolan C; Whittle M; Stirling C; Russell AJ; Mann AC; Deighan CJ
    Diabet Med; 2010 Jun; 27(6):696-700. PubMed ID: 20546290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel-precipitated rhabdomyolysis in a stable heart transplant patient.
    Burton JR; Burton I; Pearson GJ
    Ann Pharmacother; 2007 Jan; 41(1):133-7. PubMed ID: 17200431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of pharmacokinetic drug-drug interactions causing atorvastatin-induced rhabdomyolysis using physiologically based pharmacokinetic modelling.
    Li S; Yu Y; Jin Z; Dai Y; Lin H; Jiao Z; Ma G; Cai W; Han B; Xiang X
    Biomed Pharmacother; 2019 Nov; 119():109416. PubMed ID: 31518878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdomyolysis secondary to interaction between atorvastatin and fusidic acid.
    Saeed NT; Azam M
    BMJ Case Rep; 2009; 2009():. PubMed ID: 21918658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.
    Rätz Bravo AE; Tchambaz L; Krähenbühl-Melcher A; Hess L; Schlienger RG; Krähenbühl S
    Drug Saf; 2005; 28(3):263-75. PubMed ID: 15733030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.